About the Authors:
Ena Bula-Oyola
Roles Conceptualization, Data curation, Investigation, Methodology, Writing – original draft, Writing – review & editing
* E-mail: [email protected]
Affiliations Universitat Politècnica de València, Valencia, Spain, Departamento de Diseño, Universidad del Norte, Barranquilla, Colombia
ORCID logo https://orcid.org/0000-0001-9158-5830
Juan-Manuel Belda-Lois
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Supervision, Validation
Affiliations Instituto Universitario de Ingeniería Mecánica y Biomecánica, Universitat Politècnica de València, Valencia, Spain, Grupo de Tecnología Sanitaria del IBV, CIBER de Bioingeniería, Biomateriales y Nanomedicina, Valencia, Spain
ORCID logo https://orcid.org/0000-0002-7648-799X
Rosa Porcar-Seder
Roles Conceptualization, Formal analysis, Investigation, Methodology, Supervision, Validation
Affiliation: Instituto Universitario de Ingeniería Mecánica y Biomecánica, Universitat Politècnica de València, Valencia, Spain
Álvaro Page
Roles Supervision, Validation, Writing – review & editing
Affiliations Instituto Universitario de Ingeniería Mecánica y Biomecánica, Universitat Politècnica de València, Valencia, Spain, Departamento de Física Aplicada, Universitat Politècnica de València, Valencia, Spain
Introduction
Peripheral neuropathies are common pathologies. The incidence is up to 300,000 cases per year in Europe and approximately 200,000 in the United States [1]. Peripheral nerves can be damaged by autoimmune or metabolic disorders, tumours, thermal, chemical, or mechanical trauma. The leading causes are penetration, crushing, or pulling, and ischemia [2]. Most of them involve the upper limbs [3], with a higher rate of damage to the ulnar nerve, followed by the median and radial nerves [4,5]. Signs and symptoms may include partial or total motor dysfunction of the forearm and hand, loss of muscle tone and strength, hypoesthesia or hyperesthesia, pain, allodynia, or paraesthesia [6].
Rehabilitation of peripheral neuropathies has surgical and conservative alternatives. Generally, conservative treatment is considered the first option for mild to moderate injuries, while surgical treatment is standard for severe injuries or lesions that do not respond adequately to conservative management [7].
Current literature has focused on the efficacy of surgical and pharmacological treatments [8–21]. Regarding conservative treatments, most research evaluates the effects of electrophysical modalities (EM) in carpal tunnel syndrome (CTS) [22–32]. There is a gap in the study of entrapment injuries in other nerves and pathologies that represent a higher degree of disability, such as paralysis. Despite the available studies, there is no consensus about EM’s effects on improving symptoms and function. Therefore, this systematic review aims to provide a comprehensive overview of these therapies’ performance in sensorimotor rehabilitation of ulnar, radial, and median neuropathies compared to placebo, physical therapy, or between them.
Methods
We conducted a systematic review according to PRISMA guidelines (see S1 and S2 Tables). We registered our review in the PROSPERO database for systematic reviews (PROSPERO registration number CRD42020168792) and included the protocol in S1 File.
Eligibility criteria
The eligibility criteria involved studies published in English over the last forty years evaluating the effectiveness of electrophysical modalities to treat radial, ulnar, or median neuropathies. The exclusion criteria left out studies that included surgical or pharmacological treatment, animal testing, electrophysical modalities to treat other neuropathies, degenerative neuropathies, or other diseases of diverse origin with neuropathic or musculoskeletal involvement.
Outcomes measures
The primary outcomes of interest were scores on the pain scale, symptom severity, and functional status. As well as the electrophysiological parameters of the nerves: motor latency, the amplitude of motor action potential, motor conduction velocity, sensory latency, the amplitude of sensory action potential, and sensory conduction velocity. The secondary outcomes were grip and pinch strength.
Search strategy
We carried out the literature review between April and July 2019 and October 2020, using medical topic headings (MeSH) and free-text terms for neuropathies and rehabilitation to identify studies from the following databases: Biomed Central, Ebscohost, Lilacs, Ovid, PEDro, Sage, Scopus, Science Direct, Semantic Scholar, Taylor & Francis, and Web of Science. We also hand-searched the references from the studies included in the review to find other possible relevant studies. We provide an example of the search terms in the S2 File.
Data collection and analysis
Selection of studies and data extraction.
Two independent reviewers (JBL, EBO) examined all articles eligible for inclusion. We classified the data in an Excel matrix according to the type of study; nerve examined, type of injury, severity, characteristics of the participants (number, age, and sex), follow-up periods, intervention, and comparator.
Assessment of risk of bias.
Two independent reviewers (RPS, AP) assessed the bias of included studies with the Cochrane Risk of Bias tool in five domains: sequence generation, allocation concealment, blinding, incomplete data, and selective information [33]. We resolved disagreements through discussion; in cases where we did not reach a consensus, we consulted a third reviewer (JBL).
Data synthesis.
We used R Studio software to perform the meta-analysis. We pooled study results according to interventions, outcome measures, and timing of outcome measures. We did the data synthesis for each comparison group separately. In cases where it was not possible to pool the data in a meta-analysis, we provide a narrative synthesis of the results.
We assessed heterogeneity among studies using the I-squared (I2) test. We define heterogeneity using the following ranges as a guide: 0% to 40% might not be important heterogeneity, 30% to 60% might represent moderate heterogeneity, 50% to 90% might represent substantial heterogeneity, and 75% to 100% might represent considerable heterogeneity [33].
We estimated the pooled effect using standardised mean differences (SMDs) with 95% confidence intervals (CI). We used the random-effects model to perform meta-analysis when I2>50% and the fixed-effects model when I2<50%. We assessed the effect size using Cohen’s d coefficient [34] according to the following parameters: <0.2 = trivial effect; 0.2–0.5 = small effect; 0.5–0.8 = moderate effect; > 0.8 = large effect. We used a funnel plot to evaluate publication bias when we could pool at least ten studies examining the same treatment comparison [33].
We used the GRADE approach to summarise the overall quality of evidence for each outcome [35]. According to the GRADE considerations, we assess the quality of evidence across studies: risk of bias, inconsistency, indirect evidence, imprecision, and other considerations (including publication bias, large effect, plausible confounding, and dose-response gradient). We used GRADEpro GDT software (gradepro.org/) for the assessment and generation of summary tables. We provide footnotes to explain decisions to downgrade or upgrade the quality of evidence. The results of the risk of bias across studies are available in S3 Table.
Results
Search strategy
The search strategy yielded 136 results. After eliminating the duplicates, we identified 99 articles. In obtaining the full texts, we excluded several trials: thirteen per language, 42 because the approach was another therapeutic modality (e.g., acupuncture, peloid, kinesiotaping, and paraffin), three that reviewed post-surgical treatments, one whose comparator was no treatment, and two because they included steroid or vitamin B6 injection among their groups (Fig 1).
[Figure omitted. See PDF.]
Fig 1. Flowchart of the study selection process.
https://doi.org/10.1371/journal.pone.0248484.g001
Study characteristics
We identified thirty-eight studies evaluating the effectiveness of at least one EM to treat peripheral neuropathies. Thirty-four RCTs (n = 1766) assessed the effects in CTS [36–69], two (n = 93) in ulnar neuropathy at the elbow (UNE) [70,71], one comparative study (n = 19) in radial nerve palsy [72], and another (n = 107) in brachial, median, ulnar, and radial nerve palsy [73]. The characteristics and main outcomes of each study are described in S5 Table.
Assessment of risk of bias
All studies reported that participants were randomly assigned between groups, except one due to diversity between treatments [47]. However, the methods of allocation were not described in some of the studies [36,40,43,44,46,52,59,61,65]. We identified possible performance and detection biases in several studies associated with allocation concealment [37,39,43,44,47,50,51,53,55–57,63,67,68], blinding of participants [37,41–43,46,47,50–52,55–57,62,66–70], blinding of personnel [37,38,41–47,50–53,55–57,60,62,63,66–68,70,71], blinding of outcome assessors [39,42–44,46,49,55,58,60,67] that was unclear or not provided. As well as attrition [36,37,39,40,43,45,48–50,52,54,55,58,60,63,64,70,71] and data reporting biases [48,50,63,65]. In general, all studies had similar baseline characteristics and follow-up times among their groups. The results of the risk of bias assessment of the included studies are available in S4 Table.
Effects of electrophysical interventions
We obtained thirty-four RCTs evaluating CTS, eighteen comparing EMs versus placebo (i.e., LLLT alone [42,43,48,53,62,63], LLLT plus splint [49,59], ESWT plus splint [38,58], continuous US alone [39], continuous and pulsed US plus splint [45], continuous and pulsed SWD plus splint [37], SMF [40,69], PMF [61] or alternate use of both MF [44]). Four studies assessed EMs against manual therapy (MT) (i.e., LLLT [46,47], LLLT plus US [64], US plus splint, and US with MT plus splint [57]).
Six studies compared different EMs (i.e., LLLT vs. TENS [68], LLLT vs. PMF [67], LLLT vs. pulsed US [41,65], LLLT plus splint vs. continuous plus splint [52], ESWT vs. pulsed US vs. Cryo US [66], TENS vs. IFC [51]), and six studies evaluated EM versus splinting (i.e., LLLT plus splint [50,54], TENS and IFC [51], PRF plus splint [52], ESWT plus splint [55], PPNL plus splint [56]).
Two studies evaluated EMs for UNE. One RCT compared LLLT versus continuous US [70] and the other evaluated continuous SWD plus splint versus placebo [71]. Two comparative studies evaluated EMs for the treatment of hand paralysis. One compared LLLT alone versus LLLT plus splint for radial palsy [72], and the other used ultrasound, electrostimulation, thermal and manual therapy in a unified therapeutic protocol for brachial, median, ulnar, and radial palsy [73].
Electrophysical modalities versus placebo.
Favourable results for extracorporeal shock-wave therapy plus splint in pain relief, severity of symptoms, functional status, and pinch strength. Only the result for pinch strength was supported by a moderate effect size. Conflicting evidence for low-level laser therapy; favoured in three studies and participants with mild carpal tunnel syndrome. A large effect size showed superiority of placebo over electrophysical modalities. Significant improvement in motor latency, sensory amplitude, and grip strength of low-level laser therapy plus splint (trivial effect size) and inconclusive results for sensory latency, motor amplitude, sensory, and motor conduction velocity.
Lazovic et al. [48] reported pain reduction at the end of treatment in the low-level laser therapy group and expressed the results as percentages. Arikan et al. [61] reported improvements in pain (VAS) and symptom severity in the placebo group and presented their results in ranges (min/max). We did not receive the data from the authors, so we could not include them in the meta-analysis.
We found no significant differences in the remaining modalities for the parameters mentioned. The outcomes and significance are in Table 1, and detailed analyses are presented in Figs 2–12.
[Figure omitted. See PDF.]
Fig 2. Analysis—Electrophysical modalities versus placebo (pain).
Studies with more than two intervention groups (different modalities, treatment doses, or symptom classification) were numbered as (1) and (2).
https://doi.org/10.1371/journal.pone.0248484.g002
[Figure omitted. See PDF.]
Fig 3. Analysis—Electrophysical modalities versus placebo (symptoms severity).
Studies with more than two intervention groups (different modalities, treatment doses, or symptom classification) were numbered as (1) and (2).
https://doi.org/10.1371/journal.pone.0248484.g003
[Figure omitted. See PDF.]
Fig 4. Analysis—Electrophysical modalities versus placebo (functional status).
Studies with more than two intervention groups (different modalities, treatment doses, or symptom classification) were numbered as (1) and (2).
https://doi.org/10.1371/journal.pone.0248484.g004
[Figure omitted. See PDF.]
Fig 5. Analysis—Electrophysical modalities versus placebo (sensory latency).
Studies with more than two intervention groups (different modalities, treatment doses, or symptom classification) were numbered as (1) and (2).
https://doi.org/10.1371/journal.pone.0248484.g005
[Figure omitted. See PDF.]
Fig 6. Analysis—Electrophysical modalities versus placebo (motor latency).
Studies with more than two intervention groups (different modalities, treatment doses, or symptom classification) were numbered as (1) and (2).
https://doi.org/10.1371/journal.pone.0248484.g006
[Figure omitted. See PDF.]
Fig 7. Analysis—Electrophysical modalities versus placebo (sensory velocity).
Studies with more than two intervention groups (different modalities, treatment doses, or symptom classification) were numbered as (1) and (2).
https://doi.org/10.1371/journal.pone.0248484.g007
[Figure omitted. See PDF.]
Fig 8. Analysis—Electrophysical modalities versus placebo (motor velocity).
Studies with more than two intervention groups (different modalities, treatment doses, or symptom classification) were numbered as (1) and (2).
https://doi.org/10.1371/journal.pone.0248484.g008
[Figure omitted. See PDF.]
Fig 9. Analysis—Electrophysical modalities versus placebo (sensory nerve action potential amplitude).
Studies with more than two intervention groups (different modalities, treatment doses, or symptom classification) were numbered as (1) and (2).
https://doi.org/10.1371/journal.pone.0248484.g009
[Figure omitted. See PDF.]
Fig 10. Analysis—Electrophysical modalities versus placebo (compound muscle action potential amplitude).
Studies with more than two intervention groups (different modalities, treatment doses, or symptom classification) were numbered as (1) and (2).
https://doi.org/10.1371/journal.pone.0248484.g010
[Figure omitted. See PDF.]
Fig 11. Analysis—Electrophysical modalities versus placebo (grip strength).
Studies with more than two intervention groups (different modalities, treatment doses, or symptom classification) were numbered as (1) and (2). Modalities delivered with a splint were marked as (SP).
https://doi.org/10.1371/journal.pone.0248484.g011
[Figure omitted. See PDF.]
Fig 12. Analysis—Electrophysical modalities versus placebo (pinch strength).
https://doi.org/10.1371/journal.pone.0248484.g012
[Figure omitted. See PDF.]
Table 1. Outcome measures and significance of electrophysical modalities versus placebo.
https://doi.org/10.1371/journal.pone.0248484.t001
Electrophysical modalities versus manual therapy.
We observed a greater improvement (trivial effect size) in pain with low-level laser therapy versus manual therapy. We observed that fascial manipulation was superior to low-level laser therapy for symptom severity and functional status. Favourable results for low-level laser therapy in motor latency. No significant difference for low-level laser therapy plus ultrasound in neurophysiological parameters or strength. The outcomes and significance are in Table 2, and detailed analyses are presented in Figs 13–19.
[Figure omitted. See PDF.]
Fig 13. Analysis—Electrophysical modalities versus manual therapy (pain).
Studies delivering modalities with a splint were marked as (SP).
https://doi.org/10.1371/journal.pone.0248484.g013
[Figure omitted. See PDF.]
Fig 14. Analysis—Electrophysical modalities versus manual therapy (symptoms severity).
https://doi.org/10.1371/journal.pone.0248484.g014
[Figure omitted. See PDF.]
Fig 15. Analysis—Electrophysical modalities versus manual therapy (functional status).
https://doi.org/10.1371/journal.pone.0248484.g015
[Figure omitted. See PDF.]
Fig 16. Analysis—Electrophysical modalities versus manual therapy (sensory latency).
Studies delivering modalities with a splint were marked as (SP).
https://doi.org/10.1371/journal.pone.0248484.g016
[Figure omitted. See PDF.]
Fig 17. Analysis—Electrophysical modalities versus manual therapy (motor latency).
Studies delivering modalities with a splint were marked as (SP).
https://doi.org/10.1371/journal.pone.0248484.g017
[Figure omitted. See PDF.]
Fig 18. Analysis—Electrophysical modalities versus manual therapy (sensory velocity).
https://doi.org/10.1371/journal.pone.0248484.g018
[Figure omitted. See PDF.]
Fig 19. Analysis—Electrophysical modalities versus manual therapy (grip strength).
Studies delivering modalities with a splint were marked as (SP).
https://doi.org/10.1371/journal.pone.0248484.g019
[Figure omitted. See PDF.]
Table 2. Outcome measures and significance of electrophysical modalities versus manual therapy.
https://doi.org/10.1371/journal.pone.0248484.t002
Comparison between electrophysical modalities.
We found superior results with trivial effect size for pulsed US over low-level laser therapy in pain relief, symptoms, and sensory latency for carpal tunnel syndrome and ulnar neuropathy at the elbow. Favourable results for low-level laser therapy in motor latency and sensory velocity. Grip strength improved with both modalities of ultrasound over low-level laser therapy (large effect size). No significant difference for low-level laser therapy, transcutaneous electrical nerve stimulation, or ultrasound in the remaining parameters. The outcomes and significance are in Table 3, and detailed analyses are presented in Figs 20–26.
[Figure omitted. See PDF.]
Fig 20. Analysis—Comparison between electrophysical modalities (pain).
https://doi.org/10.1371/journal.pone.0248484.g020
[Figure omitted. See PDF.]
Fig 21. Analysis—Comparison between electrophysical modalities (symptoms severity).
https://doi.org/10.1371/journal.pone.0248484.g021
[Figure omitted. See PDF.]
Fig 22. Analysis—Comparison between electrophysical modalities (functional status).
https://doi.org/10.1371/journal.pone.0248484.g022
[Figure omitted. See PDF.]
Fig 23. Analysis—Comparison between electrophysical modalities (sensory latency).
https://doi.org/10.1371/journal.pone.0248484.g023
[Figure omitted. See PDF.]
Fig 24. Analysis—Ccomparison between electrophysical modalities (motor latency).
https://doi.org/10.1371/journal.pone.0248484.g024
[Figure omitted. See PDF.]
Fig 25. Analysis—Comparison between electrophysical modalities (sensory velocity).
https://doi.org/10.1371/journal.pone.0248484.g025
[Figure omitted. See PDF.]
Fig 26. Analysis—Comparison between electrophysical modalities (grip strength).
https://doi.org/10.1371/journal.pone.0248484.g026
[Figure omitted. See PDF.]
Table 3. Outcome measures and significance of the comparison between electrophysical modalities.
https://doi.org/10.1371/journal.pone.0248484.t003
Ozkan et al. [70] compared low-level laser therapy and ultrasound for ulnar neuropathy at the elbow. They reported a marked reduction in VAS pain at the end of treatment, in the first and third months of follow-up in the ultrasound group, while the low-level laser therapy group only showed improvement in the first month of follow-up. Dakowicz et al. [67] compared low-level laser therapy and pulsed magnetic field for carpal tunnel syndrome. They reported a significant reduction in VAS pain in both groups after each treatment series and six months after the last series. The authors presented their mean values through a graph. We did not receive the data from the authors, so we could not include them in the meta-analysis.
Electrophysical modalities versus splinting.
Most of the favourable results correspond to the use of splinting in conjunction with electrophysical modalities. This evidence shows a moderate effect size. We found favourable results for pain relief with pulsed Radiofrequency and low-level laser therapy plus splint and interferential current therapy alone. Significant improvement in symptom severity, functional status, sensory nerve conduction velocity, and motor latency for low-level laser therapy plus splint. No significant differences in the remaining modalities for the parameters mentioned. The outcomes and significance are in Table 4, and detailed analyses are presented in Figs 27–34.
[Figure omitted. See PDF.]
Fig 27. Analysis—Electrophysical modalities plus splint versus splinting (pain).
https://doi.org/10.1371/journal.pone.0248484.g027
[Figure omitted. See PDF.]
Fig 28. Analysis—Electrophysical modalities alone versus splinting (pain).
Studies with more than two intervention groups (different modalities) were numbered as (1) and (2).
https://doi.org/10.1371/journal.pone.0248484.g028
[Figure omitted. See PDF.]
Fig 29. Analysis—Electrophysical modalities versus splinting (symptoms severity).
https://doi.org/10.1371/journal.pone.0248484.g029
[Figure omitted. See PDF.]
Fig 30. Analysis—Electrophysical modalities versus splinting (functional status).
https://doi.org/10.1371/journal.pone.0248484.g030
[Figure omitted. See PDF.]
Fig 31. Analysis—Low-level laser plus splint versus splinting (motor latency).
https://doi.org/10.1371/journal.pone.0248484.g031
[Figure omitted. See PDF.]
Fig 32. Analysis—Electrophysical modalities alone versus splinting (motor latency).
Studies with more than two intervention groups (different modalities) were numbered as (1) and (2).
https://doi.org/10.1371/journal.pone.0248484.g032
[Figure omitted. See PDF.]
Fig 33. Analysis—Electrophysical modalities plus splint versus splinting (sensory velocity).
https://doi.org/10.1371/journal.pone.0248484.g033
[Figure omitted. See PDF.]
Fig 34. Electrophysical modalities versus splinting (sensory velocity).
Studies with more than two intervention groups (different modalities) were numbered as (1) and (2).
https://doi.org/10.1371/journal.pone.0248484.g034
[Figure omitted. See PDF.]
Table 4. Outcome measures and significance of electrophysical modalities versus splinting.
https://doi.org/10.1371/journal.pone.0248484.t004
Clinical significance
As suggested by Lemieux et al [74] and Page [75], we calculated the MCID by multiplying the pooled baseline standard deviation values by 0.2, which corresponds to the smallest effect size.
We compare the results of the meta-analysis with the references of the minimal clinically important differences for VAS (MCID of 1.2) [76], FSS (MCID of 0.74) [77], SSS (MCID of 1.04) [78], grip strength (MCID of 2.69 kg) and pinch strength (MCID of 0.68 kg) [79] and did not find any results that could be clinically significant. The overview of MCID estimation is in Table 5.
[Figure omitted. See PDF.]
Table 5. Clinical significance from MCID estimation.
https://doi.org/10.1371/journal.pone.0248484.t005
Discussion
This review included 38 studies comparing the effects of electrophysical modalities compared to placebo or other non-surgical (non-pharmacological) treatments to manage traumatic peripheral neuropathies. We carried out a detailed analysis assessing the main parameters associated with symptoms, function, strength, and nerve conduction.
We assessed the quality of evidence using the GRADE approach. The quality in most studies was classified as low or very low. Risk of bias varied between studies, but was generally serious in most domains. Heterogeneity was mostly high. All studies were small, ranging from 18 to 140 participants, so it is plausible that any effects may be overestimated.
The results of meta-analysis revealed that ESWT plus splint could improve symptoms and functional parameters in patients with mild or moderate carpal tunnel syndrome. Our findings are similar to the results from Huisstede et al. [80], who reported moderate evidence regarding the effectiveness of radial ESWT compared with placebo ESWT in the short-term. We concur with the results from Kim et al. [81], who noticed effectiveness in the outcomes mentioned above but differed in the electrophysiological parameters’ findings.
The US appears to be more effective than LLLT in improving grip strength, pain, and sensory latency. However, we found no significant differences compared to placebo or manual therapy in line with the results of Page et al. [25], who found effectiveness in the outcomes mentioned above but differed in the electrophysiological findings. We also agree with the authors, who noted there is no evidence that US applied with a splint is more effective than any other non-surgical intervention.
Similar to Huisstede et al. [80], we found limited evidence (from one RCT) that fascial manipulation can improve functional and symptom outcomes. Likewise, LLLT plus splint and PRF plus splint compared to splinting. Besides, our results showed that LLLT plus splint was superior to placebo in terms of improving grip strength in patients with mild to moderate CTS, confirming the findings of Bekhet et al. [23] and Li et al. [28]. For the rest of the parameters, we found conflicting evidence differing from the results obtained by Li et al. [28] and is consistent with those obtained by Burger et al. [30]. We agree with the observation made by Bekhet et al. [23] and Li et al. [28], highlighting the usefulness of orthoses as an agent of influencing the outcomes of peripheral neuropathies.
We found no evidence for the effectiveness of magnetic field therapy in functional and symptom improvement or electrophysiological parameters. Our findings agree with O’Connor et al. [29] and differ from Huisstede et al. [80], who reported conflicting evidence.
We found no evidence of the effectiveness of SWD, PPNL, or TENS. Our results differ from Huisstede et al. [80] for SWD and are similar concerning PPNL. We agree with Gibson et al. [82] regarding TENS. The overview of evidence is in Table 6.
[Figure omitted. See PDF.]
Table 6. Overview of evidence of electrophysical modalities.
https://doi.org/10.1371/journal.pone.0248484.t006
By contrasting effect sizes we could identify that the results favouring placebo were supported by large (for pain and symptom severity) and moderate (functional status) effect sizes. The only outcomes in favour of electrophysical modalities supported by a large effect size were associated with improvement in symptom severity and functional status in comparison to manual therapy. The superior results of splinting over electrophysical modalities were supported by moderate effect sizes. Likewise a moderate effect favoured electrophysical modalities over placebo in pinch strength. The results favouring ultrasound over the other modalities were supported by trivial effect sizes. Similarly a trivial effect size was associated with grip strength in favour of modalities over placebo and in pain improvement over manual therapy.
We contrasted the results with the minimal clinically important difference (MCID) in order to provide practical evidence to support clinical decision-making in the use of therapeutic alternatives for the management of peripheral neuropathies. We found no clinical significance in any of the pooled results when compared to the MCID.
Strengths and limitations
To our knowledge, this is the first systematic review of the effectiveness of electrophysical modalities to treat traumatic neuropathies of the wrist and hand. We used the protocols and methodological tools that ensured quality and transparency in selecting, screening, and treating data.
One of the main limitations to have a broader picture of all pathologies was the scarce availability of studies evaluating traumatic peripheral neuropathies. We found a predominance of trials studying entrapment injuries (94.7% of these trials assessed CTS), and only two trials assessed hand paralysis [72,73]. We do not include studies published in a language other than English.
Conclusions
Implications for practice
We found favourable results for ESWT and PRF in pain relief, symptom severity, functional status, sensory conduction velocity, motor latency, and motor amplitude in participants with CTS. Conflicting evidence of the effectiveness of LLLT for FSS and neurophysiological parameters in participants with mild to moderate CTS.
Continuous US was superior to LLLT in pain and symptom relief in participants with UNE. We found no evidence of benefit in other modalities and parameters.
Although we found some differences favouring electrophysical modalities, mainly when applied with a splint, none of the results obtained throughout this review can be considered clinically significant.
Implications for research
This review found mainly RCTs assessing entrapment injuries with the prevalence of CTS. More high-quality research is needed to evaluate the effectiveness of the available treatments for brachial, radial, ulnar, and median neuropathies, including those with more considerable complexity and rehabilitation time, such as axonotmesis.
Supporting information
S1 Table. PRISMA checklist.
https://doi.org/10.1371/journal.pone.0248484.s001
(DOC)
S2 Table. PICO question.
https://doi.org/10.1371/journal.pone.0248484.s002
(DOCX)
S3 Table. GRADE summary of findings.
https://doi.org/10.1371/journal.pone.0248484.s003
(PDF)
S4 Table. Risk of bias of randomised controlled studies.
https://doi.org/10.1371/journal.pone.0248484.s004
(XLSX)
S5 Table. Measures and outcomes of included studies.
https://doi.org/10.1371/journal.pone.0248484.s005
(DOCX)
S1 File. PROSPERO protocol.
https://doi.org/10.1371/journal.pone.0248484.s006
(PDF)
S2 File. Search terms.
https://doi.org/10.1371/journal.pone.0248484.s007
(DOCX)
Citation: Bula-Oyola E, Belda-Lois J-M, Porcar-Seder R, Page Á (2021) Effectiveness of electrophysical modalities in the sensorimotor rehabilitation of radial, ulnar, and median neuropathies: A meta-analysis. PLoS ONE 16(3): e0248484. https://doi.org/10.1371/journal.pone.0248484
1. Ichihara S, Inada Y, Nakamura T. Artificial nerve tubes and their application for repair of peripheral nerve injury: an update of current concepts. Injury [Internet]. 2008 Oct;39(SUPPL.4):29–39. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0020138308003999 pmid:18804584
2. Campbell WW. Evaluation and management of peripheral nerve injury. Clin Neurophysiol [Internet]. 2008 Sep;119(9):1951–65. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1388245708002058 pmid:18482862
3. Dahlin LB. (ii) Nerve injuries. Curr Orthop [Internet]. 2008 Feb;22(1):9–16. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0268089008000224.
4. Lad SP, Nathan JK, Schubert RD, Boakye M. Trends in median, ulnar, radial, and brachioplexus nerve injuries in the United States. Neurosurgery. 2010;66(5):953–60. pmid:20414978
5. Rasulić L, Puzović V, Rotim K, Jovanović M, Samardžić M, Živković B, et al. The epidemiology of forearm nerve injuries—a retrospective study. Acta Clin Croat [Internet]. 2015 Mar;54(1):19–24. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26058238. pmid:26058238
6. Scott KR, Ahmed A, Scott L, Kothari MJ. Rehabilitation of brachial plexus and peripheral nerve disorders. In: Neurological Rehabilitation [Internet]. 1st ed. Elsevier B.V.; 2013. p. 499–514. https://pubmed.ncbi.nlm.nih.gov/23312667/.
7. Federation of European Societies for Surgery of the Hand. Instructional Courses 2013. Current Treatment of Nerve Injuries and Disorders. 2013.
8. Livani B, Belangero WD, Castro de Medeiros R. Fractures of the distal third of the humerus with palsy of the radial nerve. J Bone Jt Surg—Ser B. 2006;88(12):1625–8. pmid:17159176
9. Terzis JK, Konofaos P. Radial nerve injuries and outcomes: Our experience. Plast Reconstr Surg. 2011;127(2):739–51. pmid:20966815
10. Bergmeister KD, Große-Hartlage L, Daeschler SC, Rhodius P, Böcker A, Beyersdorff M, et al. Acute and long-term costs of 268 peripheral nerve injuries in the upper extremity. PLoS One. 2020;15(4):1–12. pmid:32251479
11. Dawood I, Abd-Almoktader Abdel-Kreem M, Fareed M. EVALUATION OF TENDON TRANSFER FOR RADIAL NERVE PALSY. Al-Azhar Int Med J [Internet]. 2020 Sep 5;0(0):0–0. Available from: https://aimj.journals.ekb.eg/article_110967.html.
12. Singh S. My study on microsurgical repair of injured peripheral nerves in 1990s. IP Int J Aesthetic Heal Rejuvenation. 2020;3(1):22–8.
13. Bhat T, Mohsin M, Wani N, Zargar H, Wani A. Study of patient and injury related prognostic predictors of motor and sensory recovery in Ulnar nerve injuries—A three-year experience at tertiary care hospital in Himalayan region. Int J Surg Med. 2020;6(6):30.
14. Barbour J, Yee A, Kahn LC, MacKinnon SE. Supercharged end-to-side anterior interosseous to ulnar motor nerve transfer for intrinsic musculature reinnervation. J Hand Surg Am [Internet]. 2012;37(10):2150–9. Available from: http://dx.doi.org/10.1016/j.jhsa.2012.07.022 pmid:23021177
15. Wipperman J, Goerl K. Diagnosis and management of carpal tunnel syndrome. J Musculoskelet Med. 2016;94:47–60. pmid:28075090
16. Soldado F, Bertelli JA, Ghizoni MF. High Median Nerve Injury. Motor and Sensory Nerve Transfers to Restore Function. Hand Clin [Internet]. 2016;32(2):209–17. Available from: http://dx.doi.org/10.1016/j.hcl.2015.12.008 pmid:27094892
17. Patterson JMM. High Ulnar Nerve Injuries. Nerve Transfers to Restore Function. Hand Clin [Internet]. 2016;32(2):219–26. Available from: http://dx.doi.org/10.1016/j.hcl.2015.12.009 pmid:27094893
18. Caliandro P, La Torre G, Padua R, Giannini F, Padua L. Treatment for ulnar neuropathy at the elbow. Cochrane Database Syst Rev. 2016;2016(11). pmid:27845501
19. Evers S, Thoreson AR, Smith J, Zhao C, Geske JR, Amadio PC. Ultrasound-guided hydrodissection decreases gliding resistance of the median nerve within the carpal tunnel. Muscle and Nerve. 2018;57(1):25–32. pmid:28622409
20. Wu YT, Chen SR, Li TY, Ho TY, Shen YP, Tsai CK, et al. Nerve hydrodissection for carpal tunnel syndrome: A prospective, randomized, double-blind, controlled trial. Muscle and Nerve. 2019;59(2):174–80. pmid:30339737
21. Hentz VR. Tendon transfers after peripheral nerve injuries: my preferred techniques. J Hand Surg Eur Vol. 2019;44(8):775–84. pmid:31364477
22. Verdugo R, Salinas R, Castillo J, Cea J. Surgical versus non-surgical treatment for carpal tunnel syndrome (Review). October. 2006;(3).
23. Bekhet AH, Ragab B, Abushouk AI, Elgebaly A, Ali OI. Efficacy of low-level laser therapy in carpal tunnel syndrome management: a systematic review and meta-analysis. Lasers Med Sci. 2017;32(6):1439–48. pmid:28580494
24. Cheung WKW, Wu IXY, Sit RWS, Ho RST, Wong CHL, Wong SYS, et al. Low-level laser therapy for carpal tunnel syndrome: systematic review and network meta-analysis. Physiother (United Kingdom). 2020;106(8):24–35. pmid:32026843
25. Page MJ, O’Connor D, Pitt V, Massy-Westropp N. Therapeutic ultrasound for carpal tunnel syndrome. Cochrane Database Syst Rev. 2013;2013(3). pmid:23543580
26. Peters S, Page MJ, Coppieters MW, Ross M, Johnston V. Rehabilitation following carpal tunnel release. Cochrane Database Syst Rev [Internet]. 2016 Feb 17;(2). Available from: http://doi.wiley.com/10.1002/14651858.CD004158.pub3 pmid:27069421
27. Lim YH, Chee DY, Girdler S, Lee HC. Median nerve mobilization techniques in the treatment of carpal tunnel syndrome: A systematic review. J Hand Ther. 2017;30(4):397–406. pmid:28764878
28. Li ZJ, Wang Y, Zhang HF, Ma XL, Tian P, Huang Y. Effectiveness of low-level laser on carpal tunnel syndrome: A meta-analysis of previously reported randomized trials. Med (United States). 2016;95(31):1–6. pmid:27495063
29. O’Connor D, Marshall SC, Massy-Westropp N, Pitt V. Non-surgical treatment (other than steroid injection) for carpal tunnel syndrome. Cochrane Database Syst Rev [Internet]. 2003 Jan 20;2017(12). Available from: http://doi.wiley.com/10.1002/14651858.CD003219 pmid:12535461
30. Burger M, Kriel R, Damon A, Abel A, Bansda A, Wakens M, et al. The effectiveness of low-level laser therapy on pain, self-reported hand function, and grip strength compared to placebo or “sham” treatment for adults with carpal tunnel syndrome: A systematic review. Physiother Theory Pract [Internet]. 2017;33(3):184–97. Available from: http://dx.doi.org/10.1080/09593985.2017.1282999 pmid:28272964
31. Piazzini DB, Aprile I, Ferrara PE, Bertolini C, Tonali P, Maggi L, et al. A systematic review of conservative treatment of carpal tunnel syndrome. Clin Rehabil. 2007;21(4):299–314. pmid:17613571
32. Huisstede BM, Hoogvliet P, Franke TP, Randsdorp MS, Koes BW. Carpal Tunnel Syndrome: Effectiveness of Physical Therapy and Electrophysical Modalities. An Updated Systematic Review of Randomized Controlled Trials. Arch Phys Med Rehabil [Internet]. 2018;99(8):1623–1634.e23. Available from: https://doi.org/10.1016/j.apmr.2017.08.482 pmid:28942118
33. Centro Cochrane Iberoamericano. Manual Cochrane de Revisiones Sistemáticas de Intervenciones, versión 5.1. 0 [Internet]. Barcelona: The Cochrane Collaboration; 2012. 1–639 p. http://www.cochrane.es/?q=es/node/269%0A4.
34. Cohen J. Statistical Power Analysis for the Behavioral Sciences Second Edition.
35. Schünemann H, Brożek J, Guyatt G, Oxman A. GRADE Handbook [Internet]. 2013 [cited 2021 Jan 28]. https://gdt.gradepro.org/app/handbook/translations/es/handbook.html#h.2lwamvv.
36. Jothi KP, Bland JDP. Ultrasound therapy adds no benefit to splinting in carpal tunnel syndrome. Muscle and Nerve. 2019;60(5):538–43. pmid:31361338
37. Boyacı A. Comparison of the Short-Term Effectiveness of Short-Wave Diathermy Treatment in Patients With Carpal Tunnel Syndrome: A Randomized Controlled Trial. Arch Rheumatol [Internet]. 2014 Dec 13;29(4):298–303. Available from: http://www.archivesofrheumatology.org/full-text/600.
38. Wu Y-T, Ke M-J, Chou Y-C, Chang C-Y, Lin C-Y, Li T-Y, et al. Effect of radial shock wave therapy for carpal tunnel syndrome: A prospective randomized, double-blind, placebo-controlled trial. J Orthop Res [Internet]. 2016 Jun;34(6):977–84. Available from: http://doi.wiley.com/10.1002/jor.23113 pmid:26610183
39. Oztas O, Turan B, Bora I, Karakaya MK. Ultrasound therapy effect in carpal tunnel syndrome. Arch Phys Med Rehabil. 1998;79(12):1540–4. pmid:9862296
40. Carter R, Hall T, Aspy CB, Mold J. The effectiveness of magnet therapy for treatment of wrist pain attributed to carpal tunnel syndrome. J Fam Pract. 2002;51(1):38–40. pmid:11927062
41. Bakhtiary AH, Rashidy-Pour A. Ultrasound and laser therapy in the treatment of carpal tunnel syndrome. Aust J Physiother [Internet]. 2004;50(3):147–51. Available from: http://dx.doi.org/10.1016/S0004-9514(14)60152-5 pmid:15482245
42. Chang WD, Wu JH, Jiang JA, Yeh CY, Tsai CT. Carpal tunnel syndrome treated with a diode laser: A controlled treatment of the transverse carpal ligament. Photomed Laser Surg. 2008;26(6):551–7. pmid:19025407
43. Shooshtari SMJ, Badiee V, Taghizadeh SH, Nematollahi AH, Amanollahi AH, Grami MT. The effects of low level laser in clinical outcome and neurophysiological results of carpal tunnel syndrome. Electromyogr Clin Neurophysiol. 2008;48(5):229–31. pmid:18754533
44. Weintraub MI, Cole SP. A randomized controlled trial of the effects of a combination of static and dynamic magnetic fields on carpal tunnel syndrome. Pain Med. 2008;9(5):493–504. pmid:18777606
45. Armagan O, Bakilan F, Ozgen M, Mehmetoglu O, Oner S. Effects of placebo-controlled continuous and pulsed ultrasound treatments on carpal tunnel syndrome: A randomized trial. Clinics. 2014;69(8):524–8. pmid:25141110
46. Atya AM, Mansour WT. Laser versus nerve and tendon gliding exercise in treating carpal tunnel syndrome. Life Sci J. 2011;8(2):413–20.
47. Pratelli E, Pintucci M, Cultrera P, Baldini E, Stecco A, Petrocelli A, et al. Conservative treatment of carpal tunnel syndrome: Comparison between laser therapy and fascial manipulation®. J Bodyw Mov Ther [Internet]. 2015;19(1):113–8. Available from: http://dx.doi.org/10.1016/j.jbmt.2014.08.002 pmid:25603750
48. Lazovic M, Ilic-Stojanovic O, Kocic M, Zivkovic V, Hrkovic M, Radosavljevic N. Placebo-Controlled Investigation of Low-Level Laser Therapy to Treat Carpal Tunnel Syndrome. Photomed Laser Surg [Internet]. 2014 Jun;32(6):336–44. Available from: https://www.liebertpub.com/doi/10.1089/pho.2013.3563 pmid:24905929
49. Fusakul Y, Aranyavalai T, Saensri P, Thiengwittayaporn S. Low-level laser therapy with a wrist splint to treat carpal tunnel syndrome: a double-blinded randomized controlled trial. Lasers Med Sci [Internet]. 2014 May 30;29(3):1279–87. Available from: http://link.springer.com/10.1007/s10103-014-1527-2 pmid:24477392
50. Dincer U, Cakar E, Kiralp MZ, Kilac H, Dursun H. The Effectiveness of Conservative Treatments of Carpal Tunnel Syndrome: Splinting, Ultrasound, and Low-Level Laser Therapies. Photomed Laser Surg [Internet]. 2009 Feb;27(1):119–25. Available from: https://www.liebertpub.com/doi/10.1089/pho.2008.2211 pmid:19196106
51. Koca I, Boyaci A, Tutoglu A, Ucar M, Kocaturk O. Assessment of the effectiveness of interferential current therapy and TENS in the management of carpal tunnel syndrome: a randomized controlled study. Rheumatol Int [Internet]. 2014 Dec 12;34(12):1639–45. Available from: http://link.springer.com/10.1007/s00296-014-3005-3 pmid:24728028
52. Chen LC, Ho CW, Sun CH, Lee JT, Li TY, Shih FM, et al. Ultrasound-guided pulsed radiofrequency for carpal tunnel syndrome: A single-blinded randomized controlled study. PLoS One [Internet]. 2015;10(6):1–12. Available from: http://dx.doi.org/10.1371/journal.pone.0129918 pmid:26067628
53. Abid Ali S, Ja’afar I HZ. Low-Level Laser Therapy in the Treatment of Carpal Tunnel Syndrome. J Fac Med Baghdad [Internet]. 2012;54(3):234–8. Available from: http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/725.
54. Yagci I, Elmas O, Akcan E, Ustun I, Gunduz OH, Guven Z. Comparison of splinting and splinting plus low-level laser therapy in idiopathic carpal tunnel syndrome. Clin Rheumatol. 2009;28(9):1059–65. pmid:19544043
55. Raissi GR, Ghazaei F, Forogh B, Madani SP, Daghaghzadeh A, Ahadi T. The Effectiveness of Radial Extracorporeal Shock Waves for Treatment of Carpal Tunnel Syndrome: A Randomized Clinical Trial. Ultrasound Med Biol. 2017;43(2):453–60. pmid:27814933
56. Raeissadat SA, Rayegani SM, Rezaei S, Sedighipour L, Bahrami MH, Eliaspour D, et al. The effect of polarized polychromatic noncoherent light (bioptron) therapy on patients with carpal tunnel syndrome. J lasers Med Sci [Internet]. 2014;5(1):39–46. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25606338. pmid:25606338
57. Baysal O, Altay Z, Ozcan C, Ertem K, Yologlu S, Kayhan A. Comparison of three conservative treatment protocols in carpal tunnel syndrome. Int J Clin Pract [Internet]. 2006 May 16;60(7):820–8. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L45010648%0Ahttp://hz9pj6fe4t.search.serialssolutions.com.proxy.cc.uic.edu/?sid=EMBASE&sid=EMBASE&issn=13685031&id=doi:&atitle=Comparison+of+three+conservative+treatment+protocols+in pmid:16704676
58. Ke MJ, Chen LC, Chou YC, Li TY, Chu HY, Tsai CK, et al. The dose-dependent efficiency of radial shock wave therapy for patients with carpal tunnel syndrome: A prospective, randomized, single-blind, placebo-controlled trial. Sci Rep [Internet]. 2016;6(161):2–11. Available from: http://dx.doi.org/10.1038/srep38344 pmid:27910920
59. Evcik D, Kavuncu V, Cakir T, Subasi V, Yaman M. Laser Therapy in the Treatment of Carpal Tunnel Syndrome: A Randomized Controlled Trial. Photomed Laser Surg. 2007;25(1):34–9. pmid:17352635
60. Sim SE, Gunasagaran J, Goh KJ, Ahmad TS. Short-term clinical outcome of orthosis alone vs combination of orthosis, nerve, and tendon gliding exercises and ultrasound therapy for treatment of carpal tunnel syndrome. J Hand Ther [Internet]. 2019;32(4):411–6. Available from: https://doi.org/10.1016/j.jht.2018.01.004 pmid:29426574
61. Arikan F, Yildiz A, Kesiktas N, Karan A, Aki S, Muslumanoglu L. The effectiveness of pulsed magnetic field theraphy in idiopathic carpal tunnel syndrome: a randomized, double blind, sham controlled trial/Idiyopatik karpal tunel sendromlu hastalarda pulse manyetik alan tedavisinin etkinligi: randomize, cift kor, kontro. Turkish J Phys Med Rehabil. 2011 May 27;1+.
62. Tascioglu F, Degirmenci NA, Ozkan S, Mehmetoglu O. Low-level laser in the treatment of carpal tunnel syndrome: clinical, electrophysiological, and ultrasonographical evaluation. Rheumatol Int [Internet]. 2012 Feb 1;32(2):409–15. Available from: http://link.springer.com/10.1007/s00296-010-1652-6 pmid:21120497
63. Jiang J-A, Chang W-D, Wu J-H, Lai PT, Lin H-Y. Low-level Laser Treatment Relieves Pain and Neurological Symptoms in Patients with Carpal Tunnel Syndrome. J Phys Ther Sci [Internet]. 2011;23(4):661–5. Available from: http://joi.jlc.jst.go.jp/JST.JSTAGE/jpts/23.661?from=CrossRef.
64. Wolny T, Saulicz E, Linek P, Shacklock M, Myśliwiec A. Efficacy of Manual Therapy Including Neurodynamic Techniques for the Treatment of Carpal Tunnel Syndrome: A Randomized Controlled Trial. J Manipulative Physiol Ther. 2017;40(4):263–72. pmid:28395984
65. Saeed FUR, Hanif S, Aasim M. The effects of laser and ultrasound therapy on carpal tunnel syndrome. Pakistan J Med Heal Sci [Internet]. 2012 [cited 2020 May 27];6(1):238–41. Available from: https://www.researchgate.net/publication/287187801_The_effects_of_laser_and_ultrasound_therapy_on_carpal_tunnel_syndrome.
66. Paoloni M, Tavernese E, Cacchio A, D’orazi V, Ioppolo F, Fini M, et al. Extracorporeal shock wave therapy and ultrasound therapy improve pain and function in patients with carpal tunnel syndrome. A randomized controlled trial. Eur J Phys Rehabil Med [Internet]. 2015 Oct;51(5):521–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25697763. pmid:25697763
67. Dakowicz A, Kuryliszyn-Moskal A, Kosztyła–Hojna B, Moskal D, Latosiewicz R. Comparison of the long–term effectiveness of physiotherapy programs with low–level laser therapy and pulsed magnetic field in patients with carpal tunnel syndrome. Adv Med Sci [Internet]. 2011 Dec;56(2):270–4. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1896112614601486 pmid:22037175
68. Casale R, Damiani C, Maestri R, Wells CD. Pain and electrophysiological parameters are improved by combined 830–1064 high-intensity LASER in symptomatic carpal tunnel syndrome versus Transcutaneous Electrical Nerve Stimulation. A randomized controlled study. Eur J Phys Rehabil Med [Internet]. 2013 Apr;49(2):205–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22820819. pmid:22820819
69. Colbert AP, Markov MS, Carlson N, Gregory WL, Carlson H, Elmer PJ. Static Magnetic Field Therapy for Carpal Tunnel Syndrome: A Feasibility Study. Arch Phys Med Rehabil [Internet]. 2010 Jul;91(7):1098–104. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0003999310001991 pmid:20599049
70. Ozkan FU, Saygı EK, Senol S, Kapcı S, Aydeniz B, Aktaş İ, et al. New treatment alternatives in the ulnar neuropathy at the elbow: ultrasound and low-level laser therapy. Acta Neurol Belg [Internet]. 2015 Sep 16;115(3):355–60. Available from: http://link.springer.com/10.1007/s13760-014-0377-9 pmid:25319131
71. Bilgin Badur N, Unlu Ozkan F, Aktas I. Efficacy of shortwave diathermy in ulnar nerve entrapment at the elbow: a double-blind randomized controlled clinical trial. Clin Rehabil. 2020;34(8):1048–55. pmid:32567357
72. Oshima C, Nakazawa H, Izukura H, Miyagi M, Mizutani A, Harada T, et al. Low Level Laser Therapy for Radial Nerve Palsy Patients: Our Experience. LASER Ther [Internet]. 2018;27(1):56–60. Available from: https://www.jstage.jst.go.jp/article/islsm/27/1/27_18-OR-06/_article pmid:29795972
73. Milicin C, Sîrbu E. A comparative study of rehabilitation therapy in traumatic upper limb peripheral nerve injuries. NeuroRehabilitation [Internet]. 2018 Jan 30;42(1):113–9. Available from: https://www.medra.org/servlet/aliasResolver?alias=iospress&doi=10.3233/NRE-172220 pmid:29400678
74. Lemieux J, Beaton DE, Hogg-Johnson S, Bordeleau LJ, Goodwin PJ. Three methods for minimally important difference: no relationship was found with the net proportion of patients improving. J Clin Epidemiol [Internet]. 2007 May [cited 2021 Feb 13];60(5):448–55. Available from: https://pubmed.ncbi.nlm.nih.gov/17419955/ pmid:17419955
75. Page P. Beyond statistical significance: clinical interpretation of rehabilitation research literature. Int J Sports Phys Ther [Internet]. 2014;9(5):726–36. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25328834%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4197528. pmid:25328834
76. Kelly A-M. The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain. Emerg Med J [Internet]. 2001 May 1;18(3):205–7. Available from: http://emj.bmj.com/cgi/doi/10.1136/emj.18.3.205 pmid:11354213
77. Kim JK, Jeon SH. Minimal clinically important differences in the Carpal Tunnel Questionnaire after carpal tunnel release. J Hand Surg (European Vol [Internet]. 2013 Jan 28;38(1):75–9. Available from: http://journals.sagepub.com/doi/10.1177/1753193412442137 pmid:22457249
78. Özyürekoğlu T, McCabe SJ, Goldsmith LJ, LaJoie AS. The Minimal Clinically Important Difference of the Carpal Tunnel Syndrome Symptom Severity Scale. J Hand Surg Am [Internet]. 2006 May;31(5):733–8. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0363502306001705 pmid:16713833
79. Villafañe JH, Valdes K, Bertozzi L, Negrini S. Minimal Clinically Important Difference of Grip and Pinch Strength in Women With Thumb Carpometacarpal Osteoarthritis When Compared to Healthy Subjects. Rehabil Nurs [Internet]. 2017;42(3):139–45. Available from: http://journals.lww.com/00006939-201705000-00005 pmid:25557054
80. Huisstede BM, Hoogvliet P, Franke TP, Randsdorp MS, Koes BW. Carpal Tunnel Syndrome: Effectiveness of Physical Therapy and Electrophysical Modalities. An Updated Systematic Review of Randomized Controlled Trials. Arch Phys Med Rehabil [Internet]. 2018 Aug;99(8):1623–1634.e23. Available from: https://doi.org/10.1016/j.apmr.2017.08.482 pmid:28942118
81. Kim JC, Jung SH, Lee S-U, Lee SY. Effect of extracorporeal shockwave therapy on carpal tunnel syndrome. Medicine (Baltimore). 2019;98(33):e16870. pmid:31415424
82. Gibson W, Wand BM, O’Connell NE. Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults. Cochrane Database Syst Rev [Internet]. 2017 Sep 14;2015(11). Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L620562118%0Ahttp://dx.doi.org/10.1002/14651858.CD011976 pmid:28905362
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2021 Bula-Oyola et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Despite the available studies, there is no consensus about EM’s effects on improving symptoms and function. [...]this systematic review aims to provide a comprehensive overview of these therapies’ performance in sensorimotor rehabilitation of ulnar, radial, and median neuropathies compared to placebo, physical therapy, or between them. Two independent reviewers (RPS, AP) assessed the bias of included studies with the Cochrane Risk of Bias tool in five domains: sequence generation, allocation concealment, blinding, incomplete data, and selective information [33]. According to the GRADE considerations, we assess the quality of evidence across studies: risk of bias, inconsistency, indirect evidence, imprecision, and other considerations (including publication bias, large effect, plausible confounding, and dose-response gradient). In obtaining the full texts, we excluded several trials: thirteen per language, 42 because the approach was another therapeutic modality (e.g., acupuncture, peloid, kinesiotaping, and paraffin), three that reviewed post-surgical treatments, one whose comparator was no treatment, and two because they included steroid or vitamin B6 injection among their groups (Fig 1).
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer